60 Seconds with Mundipharma’s Susie Hackett
Susie Hackett, the new head of corporate communications at pharmaceutical company Mundipharma, talks to Gorkana about her new role, the challenges she anticipates and the audiences she aims to reach.
Susie Hackett
What are you most looking forward to in your new role at Mundipharma?
Mundipharma has a different approach to other pharmaceutical companies, and I am looking forward to working in an entrepreneurial environment that enables fresh thinking and perspectives, but also has an infrastructure that supports rapid decision-making and flexibility.
What are you hoping to achieve for the company in 2017?
Communications has been an underdeveloped function – I would like to demonstrate that with the right resource and support communications can genuinely drive strategic value.
Who will be your primary target audiences?
As with any business our audiences are varied, however we are continually reviewing the medicines development landscape, looking for opportunities to develop and commercialise potential new medicines. I will therefore be looking to reach other pharmaceutical companies and start-ups, to raise the profile of Mundipharma and what we do.
Using communications to support our ongoing business development work will be important for enabling us to build the strategic partnerships that we need and I look forward to working with our business development team in this area. Similarly I want to raise the profile of the organisation with potential new employees – we offer an exciting and invigorating work environment!
What are the key messages you will be trying to convey?
Who Mundipharma is and our philosophy and approach.
Do you anticipate any challenges?
Of course! As an underdeveloped function I will be looking to build a team and will be competing with many companies looking to hire the best communications talent.
What do you like about comms in the pharma industry?
Working in healthcare communications is challenging and highly rewarding – I am motivated by the fact that our medicines can genuinely help people live healthier and better quality lives.
